Daniel G. Tenen

Active 1976–2025

198
Papers
41,022
Citations
114
h-index
193
i10-index

Citations

Citations per year for Daniel G. Tenen1977: 2 citations1978: 8 citations1979: 4 citations1980: 3 citations1981: 8 citations1982: 8 citations1983: 19 citations1984: 9 citations1985: 11 citations1986: 10 citations1987: 8 citations1988: 9 citations1989: 25 citations1990: 25 citations1991: 27 citations1992: 29 citations1993: 51 citations1994: 103 citations1995: 94 citations1996: 125 citations1997: 172 citations1998: 228 citations1999: 240 citations2000: 202 citations2001: 216 citations2002: 431 citations2003: 335 citations2004: 271 citations2005: 414 citations2006: 380 citations2007: 527 citations2008: 402 citations2009: 440 citations2010: 427 citations2011: 419 citations2012: 347 citations2013: 398 citations2014: 373 citations2015: 424 citations2016: 311 citations2017: 358 citations2018: 309 citations2019: 897 citations2020: 1,208 citations2021: 1,245 citations2022: 885 citations2023: 683 citations2024: 946 citations2025: 457 citations2026: 16 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,874 citing papers, 31.2% of this breakdownChina: 1,888 citing papers, 12.1% of this breakdownUnited Kingdom: 951 citing papers, 6.1% of this breakdownGermany: 900 citing papers, 5.8% of this breakdownJapan: 782 citing papers, 5% of this breakdownItaly: 601 citing papers, 3.9% of this breakdownFrance: 495 citing papers, 3.2% of this breakdownCanada: 475 citing papers, 3% of this breakdownAustralia: 379 citing papers, 2.4% of this breakdownNetherlands: 373 citing papers, 2.4% of this breakdownSpain: 351 citing papers, 2.3% of this breakdownSwitzerland: 300 citing papers, 1.9% of this breakdown
0%31.2%Other 20.7%

Fields

  • Medicine44.6%
  • Biochemistry, Genetics and Molecular Biology37.6%
  • Immunology and Microbiology13.8%
  • Neuroscience2%
  • Chemistry0.3%
  • Agricultural and Biological Sciences0.3%
  • Other1.4%

Topics

  • Lung Cancer Treatments and Mutations4.2%
  • Acute Myeloid Leukemia Research4%
  • Immune cells in cancer3.1%
  • Epigenetics and DNA Methylation3.1%
  • RNA modifications and cancer2.5%
  • Immune Cell Function and Interaction2.2%
  • Other80.9%

Coauthors

All papers

Open in search
  1. Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species

    Authors: , , , , , , , , , , , , , , , , , - Immunity 2019 cited by 1,499

  2. APOE4 impairs the microglial response in Alzheimer’s disease by inducing TGFβ-mediated checkpoints

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicolás Santander, Gabriel L. McKinsey, Caroline Baufeld, Dean Sheppard, Susanne Krasemann, Roni Nowarski, Bart J. L. Eggen, Clary B. Clish, Rudolph E. Tanzi, Charlotte Madore, Thomas D. Arnold, David M. Holtzman, Oleg Butovsky - Nature Immunology 2023 cited by 194

  3. EGFR signaling pathway as therapeutic target in human cancers

    Authors: , , , - Seminars in Cancer Biology 2022 cited by 333

  4. EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

    Authors: , , , , , , , , , - New England Journal of Medicine 2005 cited by 3,939

  5. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2013 cited by 541

  6. C/EBPβ is required for 'emergency' granulopoiesis

    Authors: , , , , , , , - Nature Immunology 2006 cited by 417

  7. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer

    Authors: , , , , , , , , , , , , , , - EMBO Molecular Medicine 2018 cited by 183

  8. DNMT1-interacting RNAs block gene-specific DNA methylation

    Authors: , , , , , , , , , , , , , , , , , - Nature 2013 cited by 522

  9. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yuying Shi, Yuwen Qi, Jing Yang, Daniel G. Tenen, Li Chai, Lorelei A. Mucci, Mauricio Santillana, Hongbing Cai - Cancer Discovery 2020 cited by 1,631

  10. Transcription factors in myeloid development: balancing differentiation with transformation

    Authors: , - Nature reviews. Immunology 2007 cited by 596

  11. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 923

  12. Mapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths

    Authors: , , , , , , , , , , - Cell Reports 2019 cited by 234

  13. The Kruppel‐like factor KLF4 is a critical regulator of monocyte differentiation

    Authors: , , , , , , , , , , , , , , - The EMBO Journal 2007 cited by 324

  14. Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2009 cited by 348

  15. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , - Gut 2013 cited by 241

  16. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

    Authors: , , , , , , , , - Nature Genetics 2001 cited by 909

  17. Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 66

  18. Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation

    Authors: , , , , , , , , , , , , , , - Nature Cell Biology 2015 cited by 206

  19. Chronic interleukin-1 exposure triggers selection for Cebpa -knockout multipotent hematopoietic progenitors

    Authors: , , , , , , , , , - The Journal of Experimental Medicine 2021 cited by 56

  20. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation

    Authors: , , , , , , , , , , , , , , , , , - Blood 2005 cited by 432

  21. Metabolic alterations and vulnerabilities in hepatocellular carcinoma

    Authors: , , - Gastroenterology report 2020 cited by 77

  22. Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 62

  23. BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations

    Authors: , , , , , , , - PLoS Medicine 2007 cited by 491

  24. CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 cited by 78